Healthcare

Becker Plastic Surgery Shares Insights on the Rise of Masculine Facial Rejuvenation

Facial rejuvenation for men is evolving toward subtle refinement and structural enhancement, according to specialists at Becker Plastic Surgery in…

2 months ago

Becker Plastic Surgery Shares Insights on the Rise of Masculine Facial Rejuvenation

Facial rejuvenation for men is evolving toward subtle refinement and structural enhancement, according to specialists at Becker Plastic Surgery in…

2 months ago

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51)Narrows 2025 projected…

2 months ago

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51)Narrows 2025 projected…

2 months ago

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential

Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire…

2 months ago

Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA

REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

2 months ago

ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences

SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics…

2 months ago

PolyPid’s D-PLEX₁₀₀ Wins BioTech Breakthrough Award for “Therapeutics Solution of the Year”

PolyPid's Lead Candidate Recognized for Addressing Critical Unmet Need in Surgical Site Infection Prevention Following Positive Phase 3 ResultsPETACH TIKVA,…

2 months ago

Xenon to Present at Upcoming Investor Conferences

VANCOUVER, British Columbia and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company…

2 months ago

Commure Partners with DRH Health to Reduce Clinician Documentation Burden with MEDITECH-Integrated Ambient AI

DRH Health to Deploy AI to Streamline Clinical Workflows Across Its Care NetworkMOUNTAIN VIEW, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE)…

2 months ago